Literature DB >> 23075455

Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors.

Rayna Kim Matsuno1, Ian S Pagano, Gertraud Maskarinec, Brian F Issell, Carolyn C Gotay.   

Abstract

BACKGROUND: Complementary and alternative medicine (CAM) use is common among breast cancer survivors, but little is known about its impact on survival.
METHODS: We pooled data from four studies conducted in Hawaii in 1994-2003 and linked to the Hawaii Tumor Registry to obtain long-term follow-up information. The effect of CAM use on the risk of breast cancer-specific death was evaluated using Cox regression.
RESULTS: The analysis included 1443 women with a median follow-up of 11.8 years who had a primary diagnosis of in situ and invasive breast cancer. The majority were Japanese American (36.4%), followed by white (26.9%), Native Hawaiian (15.9%), other (10.6%), and Filipino (10.3%). CAM use was highest in Native Hawaiians (60.7%) and lowest in Japanese American (47.8%) women. Overall, any use of CAM was not associated with the risk of breast cancer-specific death (hazard ratio [HR] 1.47, confidence interval [CI] 0.91-2.36) or all-cause death (HR 0.82, 95% CI 0.63-1.06). However, energy medicine was associated with an increased risk of breast cancer-specific death (HR 3.19, 95% CI 1.06-8.52). When evaluating CAM use within ethnic subgroups, Filipino women who used CAM were at increased risk of breast cancer death (HR 6.84, 95% CI 1.23-38.19).
CONCLUSIONS: Our findings suggest that, overall, CAM is not associated with breast cancer-specific death but that the effects of specific CAM modalities and possible differences by ethnicity should be considered in future studies.

Entities:  

Mesh:

Year:  2012        PMID: 23075455      PMCID: PMC3810617          DOI: 10.1089/jwh.2012.3698

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  38 in total

1.  An exploratory study of social support, distress, and life disruption among low-income Hispanic women under treatment for early stage breast cancer.

Authors:  S M Alferi; C S Carver; M H Antoni; S Weiss; R E Durán
Journal:  Health Psychol       Date:  2001-01       Impact factor: 4.267

2.  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Authors:  J S McLay; D Stewart; J George; C Rore; S D Heys
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

3.  Stretched-exponential decay of the luminescence in porous silicon.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1993-12-15

4.  Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden.

Authors:  Maria Hietala; Maria Henningson; Christian Ingvar; Per-Ebbe Jönsson; Carsten Rose; Helena Jernström
Journal:  Acta Oncol       Date:  2010-05-25       Impact factor: 4.089

5.  Changes in the cortisol awakening response (CAR) following participation in mindfulness-based stress reduction in women who completed treatment for breast cancer.

Authors:  Rose H Matousek; Jens C Pruessner; Patricia L Dobkin
Journal:  Complement Ther Clin Pract       Date:  2010-11-26       Impact factor: 2.446

6.  Ethnic differences in complementary and alternative medicine use among cancer patients.

Authors:  G Maskarinec; D M Shumay; H Kakai; C C Gotay
Journal:  J Altern Complement Med       Date:  2000-12       Impact factor: 2.579

7.  Use of alternative medicine by women with early-stage breast cancer.

Authors:  H J Burstein; S Gelber; E Guadagnoli; J C Weeks
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

8.  Use of complementary and alternative medicine in Hawaii cancer patients.

Authors:  C C Gotay; W Hara; B F Issell; G Maskarinec
Journal:  Hawaii Med J       Date:  1999-04

9.  Classification of CAM use and its correlates in patients with early-stage breast cancer.

Authors:  Juliann Saquib; Lisa Madlensky; Sheila Kealey; Nazmus Saquib; Loki Natarajan; Vicky A Newman; Ruth E Patterson; John P Pierce
Journal:  Integr Cancer Ther       Date:  2011-03-07       Impact factor: 3.279

10.  A longitudinal investigation of coping strategies and quality of life among younger women with breast cancer.

Authors:  Suzanne C Danhauer; Sybil L Crawford; Deborah F Farmer; Nancy E Avis
Journal:  J Behav Med       Date:  2009-03-24
View more
  10 in total

1.  Prevalence and frequency of self-management strategies among female cancer survivors: the neglected roles of social relations and conscious living.

Authors:  Monika Sieverding; Nadine Ungar; Alexandra Fleischmann; Miruh Lee; Haitong Zhang; Margaux Mohnke; Nicole K Specht; Gerdi Weidner
Journal:  Support Care Cancer       Date:  2019-05-18       Impact factor: 3.603

2.  Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.

Authors:  Heather Greenlee; Alfred I Neugut; Laura Falci; Grace Clarke Hillyer; Donna Buono; Jeanne S Mandelblatt; Janise M Roh; Isaac J Ergas; Marilyn L Kwan; Marion Lee; Wei Yann Tsai; Zaixing Shi; Lois Lamerato; Lawrence H Kushi; Dawn L Hershman
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

Review 3.  Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.

Authors:  Heather Greenlee; Lynda G Balneaves; Linda E Carlson; Misha Cohen; Gary Deng; Dawn Hershman; Matthew Mumber; Jane Perlmutter; Dugald Seely; Ananda Sen; Suzanna M Zick; Debu Tripathy
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

Review 4.  Economic constraints - the growing challenge for Western breast cancer centers.

Authors:  Rene P Seidel; Michael P Lux; Josef Hoellthaler; Matthias W Beckmann; Wieland Voigt
Journal:  Breast Care (Basel)       Date:  2013-03       Impact factor: 2.860

Review 5.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

Review 6.  Cancer survivorship services for indigenous peoples: where we stand, where to improve? A systematic review.

Authors:  Bridget M Cavanagh; Claire E Wakefield; Jordana K McLoone; Gail Garvey; Richard J Cohn
Journal:  J Cancer Surviv       Date:  2015-09-07       Impact factor: 4.442

7.  Complementary and Alternative Medicine Use and Latina Breast Cancer Survivors' Symptoms and Functioning.

Authors:  Christina L Rush; Tania Lobo; Adriana Serrano; Maxie Blasini; Claudia Campos; Kristi D Graves
Journal:  Healthcare (Basel)       Date:  2016-10-31

Review 8.  Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.

Authors:  Grayson A Roumeliotis; Genevieve Dostaler; Kirsty U Boyd
Journal:  Plast Surg (Oakv)       Date:  2017-08-22       Impact factor: 0.947

9.  Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

10.  Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer.

Authors:  Garrett Strizich; Marilie D Gammon; Judith S Jacobson; Melanie Wall; Page Abrahamson; Patrick T Bradshaw; Mary Beth Terry; Susan Teitelbaum; Alfred I Neugut; Heather Greenlee
Journal:  BMC Complement Altern Med       Date:  2015-11-19       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.